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TIIVISTELMÄ 
Tässä pro gradu -tutkielmassani esittelen menetelmät, joita käytettiin ensimmäisissä yrityksissä 
määrittää taksonomisesti seeprakalan suun ja suoliston mikrobiston kolmesta seeprakalayksilöstä. 
Tavoitteena tutkimuksessa on auttaa selvittämään mahdollisuutta käyttää seeprakalaa 
malliorganismina suun mikrobiston ja sen tasapainon järkkymisen tutkimisessa ja 
hoitostrategioiden kehittämisessä.   Tutkimuksessa käytettiin hyväksi mikrobistojen tutkimuksessa 
oletusarvoiseksi menetelmäksi vakiintunutta bakteerien ja arkkien ribosomaalisen pienen 
alayksikön RNA:ta koodaavan 16S geenin sekvensointia Illumina MiSeq sekvensaattorilla. 
Sekvensointikirjaston luomiseen kokeiltiin eri lähestymistapoja, joista lopulta päädyttiin 
käyttämään Illuminan valmistamaa kirjastonvalmistuspakkausta. Tulosten perusteella seeprakalan 
suun ja suolen mikrobistot vaikuttavat olevan samankaltaisia, mutta analyyseissa kuitenkin selkeästi 
omiksi kokonaisuuksiksi ryhmittyviä. Suun mikrobistossa runsaslukuisimpana esiintyivät 
firmikuutteihin kuuluvat peptostreptococcaceae heimon bakteerit ja toisiksi yleisimpinä 
proteobakteereihin lukeutuvat aeromonadaceae heimon edustajat. Suolen mikrobistossa kahden 
yleisimmän heimon järjestys on päinvastainen. Suun mikrobistot olivat tutkimuksen perusteella 
suolen mikrobistoja lajirikkaampia ja niiden määräsuhteet olivat myös tasaisemmin jakautuneet 
Shannonin indeksillä mitattuna. Tulosten perusteella seeprakalan käyttömahdollisuudet suun 
mikrobiston mallintamiseen vaikuttavat lupaavilta. 
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ABSTRACT 
In this master’s thesis I present the methods that was used in the first efforts to taxonomically 
characterise the zebrafish oral and gut microbiotas from three individual zebrafish. Purpose of the 
study is to assess the use of the zebrafish as a model organism for studying the oral microbiota and 
for testing treatment strategies for microbiome disruption in the oral environment. In the study, 
sequencing of bacterial and archaeal ribosomal small subunit 16S RNA coding gene with Illumina 
MiSeq sequencer was used, a method that has been established as a standard tool in microbiome 
studies. Different approaches for creating the sequencing library were tested, of which the Illumina 
library preparation kit was eventually used for creating the sequencing library. Based on the results, 
the microbiotas in zebrafish oral and gut environments are rather similar, yet distinguishable. The 
most abundant microbes in the oral environment were bacteria from the Firmicutes phylum, which 
belongs to the Peptostreptococcaceae family and the second most abundant family was 
Aeromonadaceae that is part of the Proteobacteria phylum. In the gut microbiota two most 
abundant families were the same as in the oral environment, but in the opposite order. In oral 
microbiota there were higher taxonomic diversity than in the gut microbiota and the relative 
abundances between taxons were more evenly distributed when measured with Shannon’s index. 
Based on these results, the potential of the zebrafish for modelling oral microbiota seem promising. 
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Figure 1. The artist rendering of the oral biofilms. The bacteria (round) has excreted extracellular components (stringy fibres) for 
protection and attachment. The submarine is not in scale and exist solely for aesthetic purposes. Illustration by courtesy of artist Sonja 
Suokko, 2019. 
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1 ABBREVIATIONS 
CD   Crohn’s disease 
CNS   Central nervous system 
CPR   Candidate phyla radiation 
Dpf   Days post fertilization 
EAE   Experimental autoimmune encephalomyelitis 
FMT   Faecal microbiota transplantation 
GALT   Gut-associated lymphoid tissue 
IBD   Inflammatory bowel disease 
NGS   Next generation sequencing 
OMT   Oral microbial transplantation 
PTU   1-phenyl-2-thiourea 
SCFA   Short chain fatty acids 
Treg   Regulatory T-cell 
UC   Ulcerative colitis  
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2 INTRODUCTION 
Microbial inhabitants residing on human epithelia have recently been understood having a role in 
various conditions affecting people worldwide, both in health and disease. For long time it has been 
known how certain bacteria associates with disease. Robert Koch formed the famous Koch’s 
postulates about how microbial species derived from patient, grown in laboratory and injected into 
healthy individual causes similar disease, confirms that microbe to be causal factor for the disease. 
Newly acquired knowledge of microbiology has taught us to see deeper into the issue and those 
postulates that stayed long as unchanged rule of nature, have become if not fully outdated at least 
insufficient to explain all the microbial associated diseases known today. Last few decades have 
brought massive leaps for technology in microbiology and these new tools have given birth to 
entirely new branch inside the field of science. The key new tool from microbiology perspective has 
been the next generation sequencing that has become more efficient and cheaper to use during 
recent years. The taxonomic characterisations by sequencing conserved microbial genes have 
provided unprecedented amount of data of complex microbial colonies. It has assisted in gaining 
insight into microbial interactions and why dysbiosis; the state of microbiome where the microbial 
community and host cannot maintain the beneficial composition and metabolism of the 
microbiome, leads to the disease states that are visible in macro perspective. Studies have been 
conducted with healthy individuals, patients with diseases that are potentially associated with 
microbiome and in dedicated animal models. Each method contributes to the growing pool of 
information but has their limitations. Studies on healthy individuals tells how microbiota-host 
interactions are organised while homoeostasis is intact but are unable to tell which factors are 
necessary to maintain it. Studies on patients provide valuable data on disease states, yet the 
practical reasons usually limit the data to the state of microbiota where disease has already 
emerged, thus animal models are needed to be able to study the progression of microbial dysbiosis 
and its effect on disease phenotype in controlled and systematic manner. However, animal models 
are inevitably different from humans and that reflects also into composition and functions of 
anatomic microbiomes. Since neither of these means to gather information is not enough on its 
own, combination of them all is needed to uncover the secret life of microbes on human anatomic 
microbial environments. A lot is known about the gut microbiome and there are already studies 
with all the methods described above. As an example, microbiome disruption in gut is known to be 
associated with inflammatory bowel disease, which is confirmed with patients in clinical settings 
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and studied systematically with mouse and rat models. Despite of the anatomic differences 
between rodents and human, those studies have provided means to study the effect of genes and 
environmental factors to changing microbiome and microbiome’s effect on disease progression. 
While gut is relatively well known, other anatomic microbiomes are less studied. Oral microbiome 
dysbiosis is known to relate to certain oral diseases, caries and periodontitis being the most 
commonly known examples. Both of those are multifactorial diseases that have strong association 
with dysbiosis and are among the most common diseases on the planet. While patient samples are 
abundant and easy to obtain, there is shortage of animal models that could be used to test 
treatment strategies for restoring a health enhancing microbiome composition in oral environment. 
This thesis presents efforts made for establishing zebrafish as an animal model for studying the oral 
microbial dysbiosis. 
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3 LITERATURE REVIEW 
3.1 Microbiomes 
The definition of microbiome in short is all the microscopic species that inhabit certain environment, 
the genes they have and express, interactions between species and the environment itself, and the 
environmental conditions that affect the inhabitant species. Microbiome includes all species that 
are contributing to the composition and function of the microbiome including yeasts, fungi, 
protozoans, helminths, viruses and not just bacteria that usually is the most abundant kingdom 
among the microbiome. As bacteria is the most well-known kingdom among microbial organisms, 
this thesis focuses especially on bacteria as part of the microbiome.  One characteristic feature that 
is common for microbiomes in every environment is the dynamic nature of these micro ecosystems. 
Figuratively speaking, the seemingly static surface is revealed to be in constant motion once 
spectated closer. State of the microbiome is determined by the environmental factors and its ability 
to adapt into the changing conditions. Microbes are not isolated entities, only affected by the 
environment, but they are a part of a complex web of interactions that determines their fate in the 
larger microbial community. The environment and the resources it can provide for inhabitants 
dictates which features are required to fill available ecological niches. This thesis aims to further the 
knowledge about microbiomes as a part of human-microbiota supraorganism. Microbiomes of 
anatomic sites of vertebrates are having either direct or instrumental importance for achieving the 
goal and are therefore discussed in this text.   
Human microbiomes can be divided roughly into four categories, i.e. skin, respiratory tract, 
gastrointestinal tract and urogenital microbiomes, which all are characteristically different in 
species composition and diversity (Huttenhower et al., 2012). Each of these anatomic sites is 
affected by different environmental forces that are shaping the survival requirements for microbes. 
For example, the skin microbiota is further divided into three groups based on the properties of 
skin, i.e. sebaceous, moist and dry areas of skin, which all have distinct microbiomes (Byrd, Belkaid 
and Segre, 2018). A metagenomics study of different skin sites found that the metabolic profiles of 
microbiomes between these sites have major differences (Oh et al., 2014). Despite differences, 
certain core metabolic functions exist in all skin microbiomes, the amino acid, nucleotide and lipid 
metabolism being the most widely shared pathways between different sites, yet significant 
variations in gene compositions of these pathways exist (Oh et al., 2014). These differences arise 
from different environmental factors affecting each skin microbiomes. Moist skin, characterized by 
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an abundance of sweat glands, is acidic and contains antimicrobial molecules secreted in sweat. This 
favours microbes capable of tolerating high salt concentration and utilizing urea as nitrogen source, 
such as Staphylococcus spp. or Corynebacterium (Scharschmidt and Fischbach, 2013). Sebaceous 
skin regions favours lipophilic microbes (Grice et al., 2009). Propionibacterium acnes is capable of 
cleaving arginine from skin proteins with proteases (Holland, Greenman and Cunliffe, 1979) and 
utilizing sebaceous gland excretions with triglyceride degrading lipases (Brüggemann et al., 2004). 
In addition to acting as an energy source lipase degraded triglycerides forms free fatty acids, which 
have antimicrobial properties (Yoon et al., 2018) and thus contributes to the host resistance. 
Microbial profiles also differ throughout life in response to changing environmental factors, such as 
increased sebum excretion in puberty (Oh et al., 2012). 
3.1.1 The oral microbiome 
Similarly to skin microbiomes, which were discussed above, the microbial environment is not 
uniform throughout the oral cavity. On the contrary, vast differences in species composition and 
dominant species are evident along the salivary gradient and on different surfaces (Proctor et al., 
2018). A few genera of microbes make the most of the abundance of the species diversity and only 
a few species make up a significant proportion of the total mass of the oral microbiota (Huttenhower 
et al., 2012; Hall et al., 2017). As in other anatomic sites, each individual has a unique microbiota 
that is relatively stable over time (Flores et al., 2014; Hall et al., 2017). Some individuals have higher 
tendency for oral diseases due to inhabitant species of microbiome and their metabolic properties 
(Rosier, Marsh and Mira, 2018).  
The oral microbiota is characteristically a diverse community that encounters a wide array of 
microbes throughout the day (David et al., 2014). Most of these species are merely passing by (David 
et al., 2014) lacking the advantageous traits needed for establishing themselves as a permanent 
occupant: adhesion molecules to attach themselves to mucosal pellicle (Hannig et al., 2017) and to 
existing biofilm (Figure 1.) (Nobbs, Jenkinson and Jakubovics, 2011) and molecular mechanisms to 
process available nutrients in molecular networks (Marsh and Zaura, 2017). 
Planktonic bacteria, unable to attach to oral biofilms are targeted by numerous antimicrobial 
substances (Bechinger and Gorr, 2017) and drained to the oesophagus by the constant flow of saliva. 
Saliva is a complex mix of peptides, glycoproteins, antibodies, ions, amino acids and other small 
molecules (Marsh et al., 2016) that maintains oral homeostasis by buffering the pH (Li et al., 2007) 
and preventing microbial growth in a number of ways including direct killing (Roversi et al., 2014) 
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and scavenging important nutrients such as iron (Rosa et al., 2017). These properties make saliva 
one of the most important defence systems in the oral environment, which ensures that the 
temporal existence of potentially harmful microbial species does not evolve into lasting 
inhabitation. 
Where the exact species composition in each mouth is unique, there are species of certain key 
genera that are likely inhabitants of every microbiome. The most characteristic genera of microbes 
are Streptococcus spp., (Huttenhower et al., 2012) which include members that are associated with 
beneficial properties for the host (Ho, Lamont and Xie, 2017) but also notorious pathogens, such as 
caries inducing Streptococcus mutans (Esberg et al., 2019). Streptococcus species are important for 
cross species interactions, since they have a crucial role in formation of biofilms on oral surfaces 
(Nobbs, Jenkinson and Jakubovics, 2011). They express adhesion molecules on their cell membrane, 
which have a binding specificity for pellicle proteins (Brady et al., 2010; Lizcano, Sanchez and 
Orihuela, 2012). Thus Streptococcus spp. act as early colonizers (Mashima and Nakazawa, 2015), 
which defines the further composition of the forming biofilms (Mishra et al., 2010)  
Streptococci are major phyla responsible for early colonization and adhesion to the acquired enamel 
pellicle. In the formation of oral multispecies biofilms, a group of microbial species play a key role 
by binding to the early colonizers. These bridge species share a common feature of expressing a set 
of adhesion molecules on their surface that can bind a vast selection of other bacteria (Nobbs, 
Jenkinson and Jakubovics, 2011). Fusobacteria are the most common example of these adapter 
species that can be found in most of the population. They attach themselves to the early biofilm 
with adhesins such as RadD that interacts with the streptococcal SpaP adhesin (Guo et al., 2017) 
and expresses other adhesins, such as Fap2 (Coppenhagen-Glazer et al., 2015) and FomA (Liu et al., 
2010) that readily bind to other microbes with a nearly universal binding specificity. Fusobacteria 
can be found in nearly all mouths and the members in this genus have both commensal and 
pathogenic properties (Brennan and Garrett, 2019) 
Microbe-microbe interactions in oral environments are not limited to the previously described 
formation and adhesion to existing biofilms. One example of this kind of relationship is between 
Actinomyces odontolyticus XH001 and member of relatively recently found Candidate phyla 
radiation (CPR) species TM7x, where the latter is acting as an ectoparasite for XH001 (He et al., 
2015). TM7x lacks many essential genes, including genes required for amino acid synthesis and is 
thus dependent on the host for providing nutrients. Newly found interaction of these two species 
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indicates that there is still much to learn about oral microbial ecology. Many other CPR species are 
found in the oral environment as well and due to their small genome and physical size, it seems to 
be possible that they might be reliant on parasitic relationships with other microbes (Baker et al., 
2017). 
 
3.2 The effect of the microbiome on health 
3.2.1 Overview 
Commensal microbes are important for the development and maturation of the immune system 
and therefore the disruption of these interactions might lead to severe consequences. In the gut, 
the commensal microbiome can induce the maturation of regulatory T-cells (Treg) with at least a 
few different mechanisms (Petersen and Round, 2014). The commensal gut bacterium Bacteroides 
fragilis is able to induce the conversion of gut peripheral CD4+ T-cells into Tregs by producing 
polysaccharide A (PSA) which binds to TLR2 receptors on dendritic and T-cells. This leads to the 
production of IL-10 (Round and Mazmanian, 2010), a known anti-inflammatory cytokine. Certain 
Clostridium species generate the same outcome by inducing production of TGF-β cytokine, which 
guide the naïve T-cell to differentiate towards Tregs, with short chain fatty acids (SCFA) in the gut 
epithelia (Narushima et al., 2014). Tregs are important for a mechanism called oral tolerance, which 
allows food antigens and gut commensal bacteria to pass through gut without inducing 
inflammation (Commins, 2015). Therefore, the disruption of these processes can lead to a 
decreased tolerance of self-antigens and the commensal microbiome (Petersen and Round, 2014). 
These two microbiome-host interactions serve as examples of the ways how microbiota can 
positively affect the health of the host. 
3.2.2 Dysbiosis 
The microbiota plays a pivotal role in host health and therefore, it is not surprising to learn that an 
abnormal microbiota can lead to variety of consequences from mild to severe. This chapter gives a 
few examples of how the so called microbial dysbiosis can cause certain diseases. The state of the 
microbiota where the homeostasis is disrupted is called dysbiosis. It is the result of a change in key 
environmental factors that drives and maintains the default state of the microbiota. Changes that 
precede the dysbiotic microbiome includes shifts in behavioural or dietary habits (Vallès et al., 2018; 
Xu et al., 2019), antibiotic usage (Stanisavljević et al., 2019) or non-antibiotic medicine (Le Bastard 
et al., 2017), and they lead to a decrease in the overall species diversity, loss of beneficial microbes 
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and potentially, an introduction of pathogens or their increased abundance. Dysbiosis is reported 
to be a factor in many inflammatory and autoimmune diseases including cancer (Gagnière et al., 
2016).  Dysbiosis can also act in concert with disease predisposing genes in causing disease 
phenotype. In inflammatory bowel syndrome (IBD) mutation in the TLR5 gene is associated with 
IBD. In a study that was conducted with TLR5-/- knockout mice, the IBD disease phenotype was only 
seen, when the mice gut microbiota contained certain proteobacteria such as Escherichia coli 
(Carvalho et al., 2012).  
In a study conducted with experimental autoimmune encephalomyelitis (EAE) Dark Agouti rats, 
orally administered antibiotics disturbed the gut microbiota, which led to increased inflammation 
in the central nervous system (CNS) (Stanisavljević et al., 2019). A shift in the microbiome was 
observed along with increased gut-associated lymphoid tissue (GALT) activation. The proportion of 
Firmicutes, Actinobacteria, Clostridia and Bacilli were decreased, while Proteobacteria, 
Bacteroidetes and gammaproteobacteria increased in abundance. This led to a decrease in total 
abundance of SCFA in the gut and to a following inflammation in the GALT that resulted in the failure 
of regulating autoimmunity in CNS. This study shows that dysbiosis can have far reaching severe 
consequences. 
Studies on the role of the environment on the human microbiome has shown that lower 
environmental diversity near home during childhood negatively correlates with increased 
susceptibility for atopic dermatitis (Hanski et al., 2012). The general diversity of 
gammaproteobacteria in the skin microbiota was significantly lower in atopic study subjects than in 
the control group. The control group had also significantly higher anti-inflammatory cytokine IL-10 
levels than the atopic group. IL-10 levels correlated with abundance of gammaproteobacteria 
Acinetobacter on skin. The study suggests that environmental microbes have a role in host 
immunomodulation and in the overall health of the population, thus enforcing the hygiene 
hypothesis. 
3.2.3 Oral dysbiosis 
Most of the dysbiosis studies concentrate on the gut microbiome, and much more data have been 
accumulated on gut dysbiosis related diseases than on other anatomical site microbial 
environments. The oral cavity has its share of diseases, where dysbiosis serves as a causative factor. 
All types of oral cancers combined are among the deadliest cancers in the world (Ferlay et al., 2015), 
and recent studies have shown a correlation between microbial dysbiosis and oral cancers, yet no 
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causality can be drawn from the results (Banerjee et al., 2017).  Microbial profile changes have been 
notable in the abundances of certain key genera, while species composition have remained constant 
between tumour patients and controls (Wang et al., 2017). Actinobacteria and especially the genus 
Actinomyces were decreased in abundance, while the genus Parvimonas was increased in tumour 
patients (Wang et al., 2017).  
One well-known and extensively studied oral disease is caries, a disease in which the dental enamel 
is slowly demineralized by acidifying bacterial metabolism. Caries has long been known to be caused 
by bacteria, but only relatively recently has the multifactorial nature of the disease begun to unravel 
(Pitts et al., 2017). The likelihood of caries formation is increased when following conditions are 
met: a frequent dietary sugar intake (Moynihan and Kelly, 2014), poor oral hygiene (Kumar, 
Tadakamadla and Johnson, 2016), and also the caries inducing composition of microbiome . A group 
of acid producing and acid tolerating bacteria, not limited to the notorious caries pathogen 
Streptococcus mutans, are co-operatively forming the disease promoting state (Simón-Soro and 
Mira, 2015). Many bacterial species have been shown by 16S gene sequencing to co-exist in caries 
lesions, yet mechanistic studies of the interactions are not abundant. However, in one in vitro study, 
S. mutans and A. actinomycetemcomitans were co-cultivated in artificial saliva and the latter species 
was shown to activate S. mutans quorum sensing, which led to the formation of a dual species 
biofilm and S. mutans to change its gene expression profile from oxidative stress related genes to 
anaerobic metabolism, chaperones and iron acquisition (Szafrański et al., 2017). The virulence of 
both species was enhanced as the facultative anaerobe S. mutans could form anaerobic conditions 
inside the biofilm and A. actinomycetemcomitans was not able to form biofilm without the presence 
of S. mutans (Szafrański et al., 2017).  
Even though the oral environment contains a wide variety of fungi, there are relatively few studies 
concentrating on it. To date more than 75 genera have been found in healthy mouths (Ghannoum 
et al., 2010). As the number of studies on mycobiome remains low, not much is known about all the 
inhabitant fungi in the mouth, but some of them are known opportunistic pathogens, which cause 
infections especially in immunocompromised patients. As an example, Candida albicans is 
commonly seen to cause oral candidiasis in AIDS patients (de Repentigny, Goupil and Jolicoeur, 
2015). Apparently, the microbiome is regulating the abundance of oral C. albicans, Aggregatibacter 
actinomycetemcomitans, a known oral pathogen itself (Fine et al., 2007), is inhibiting C. albicans 
growth via quorum sensing by binding to its hyphae (Bachtiar et al., 2014). 
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3.2.4 Possibilities in medicine 
As the research community has learned about the importance of host-microbiome interactions in 
health and disease, it has given rise to novel approaches to treat the affected conditions. To date 
the most successful example that has paved the way for the treatment of other conditions, is faecal 
microbiota transplantation (FMT), which has been used for the treatment of Clostridium difficile 
derived diarrhoea (Cammarota, Ianiro and Gasbarrini, 2014)  and ulcerative colitis (UC) (Moayyedi 
et al., 2015). UC is a gut disorder, which is caused by  changed microbial environment in the gut that 
results in chronic inflammation (Ungaro et al., 2017). The onset of UC includes genetic 
predisposition in certain leukocyte and barrier function associated genes and the administration of 
several drugs including non-steroidal anti-inflammatory drugs and oral contraceptives (Ungaro et 
al., 2017). Fecal microbiota transplantation has shown significant increase in the remission rate 
compared to a placebo: 24% vs. 5% of patients respectively entered remission in this double-blinded 
clinical trial (Moayyedi et al., 2015). After the treatment, FMT treated patients’ gut microbiome was 
significantly more diverse and reminded that of the donor’s. Depending on the donor, either the 
enrichment of Lachnospiraceae and Ruminococcus or Escherichia and Streptococcus was observed 
(Moayyedi et al., 2015).   
These early FMT treatment studies provide an interesting and novel approach to treat certain 
microbiome associated diseases. To date, most studies have concentrated on the gut microbiome. 
While some promising results have been seen, there remains a need to elucidate the mechanistic 
principles of microbe-microbe and microbe-host interactions to make these microbiome 
substitutions a viable and safe option for treatment.  Similar strategies have been visioned for 
microbiomes colonizing other human anatomic locations, as basic principles behind dysbiosis 
associated diseases remain the same throughout microbiomes; a certain composition of the 
microbiota is a driving factor for disease and therefore substituting the dysbiotic microbiome with 
the microbiome of a healthy donor should alleviate symptoms of the disease.  
Different strategies for the treatment of oral microbiome dysbiosis have been proposed, including 
treatment with probiotics or with oral microbial transplantation (OMT). The probiotic approaches 
have been attempts to affect the oral microbiota by introducing single or few characterised 
microbial species to dysbiotic subjects, but more evidence for their efficiency and safety are needed 
(Gruner, Paris and Schwendicke, 2016). The OMT strategy is very similar to FMT, yet the practical 
administration of the microbiome transplant has some key differences due to the characteristics of 
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the oral microbial environment (Nascimento, 2017). The proposed method for performing the 
transplantation can be divided into three steps: first, the collection of microbiota from healthy 
donor, second, the removing of the dysbiotic microbiota from the patient and third, the 
transplantation of the harvested microbiome to the patient (Pozhitkov et al., 2015). In the first step 
the problem lies in recognising the composition of a healthy microbiome, although it has been the 
subject of many studies, which have provided the means for estimating the pathogenicity of the 
microbial composition (García-Jiménez and Wilkinson, 2019). Stabile microbiotas have intrinsic 
ability to resist changes in the species composition (Rosier, Marsh and Mira, 2018). Therefore, the 
attempts to reinstate a healthy microbiome requires disturbation of prevailing conditions. Multiple 
techniques for achieving that has been examined. In addition to rigorous oral hygiene measures, 
bactericidal mouth rinses have been used, chlorhexidine being one and sodium hypochlorite 
another tested substance. Chlorhexidine has been shown to be effective in killing oral bacteria in 
attempts to boost the efficiency of oral probiotic administration (Aminabadi et al., 2011). However, 
due to its property of adhering to oral mucosal tissue, it remains bactericidal long after 
administration (Cousido et al., 2010) and thus also affects the transplanted healthy microbiome. 
Sodium hypochlorite has been proven to be a better alternative to chlorhexidine as its bactericidal 
effects can be neutralised with a sodium ascorbate buffer (Pozhitkov et al., 2015). 
3.2.5 Animal models of dysbiosis 
There are already some animal models for studying dysbiosis, the most common organism in use 
being mouse and rat, but also zebrafish (He et al., 2013) and even Drosophila melanogaster (Lee 
and Lee, 2014) have been used. Different forms of IBD are the most studied of dysbiotic diseases 
and that reflects the abundance of animal models available. In mice, knock-out strains of certain IBD 
related genes have been made. The intracellular pathogen receptor NOD2-/- knock-out mice 
combined with an infection of protozoan Giardia muris and Toxoplasma gondii, and indomethacin 
results in a T-cell mediated disease state that resembles Crohn’s disease (CD) in the mouse ileum 
(Craven et al., 2012). In this model effect of different microbial compositions and treatment 
strategies for the disease are easily studied. In the same NOD2-/- knock-out study, another mouse 
model was presented for CD, in which the pro-inflammatory cytokine receptor CCR2 was knocked-
out. These CCR2-/- mice show a significant decrease of the CD phenotype and dysbiosis when 
infected with T. gondii (Craven et al., 2012) 
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Lee and Lee (2014) reviewed the use of fruit fly D. melanogaster for studying the role of gut 
microbial dysbiosis for IBD-like disease condition. The article also summarises the principles of 
performing gut microbial community studies by using a standardized Drosophila gut commensal 
microbiome in sterile conditions to control the effects of treatments or for example diets. The 
Drosophila has also been used for studying the effects of dysbiosis on Alzheimer’s disease (Wu et 
al., 2017). The study found that vacuolar degeneration in the human amyloid Aβ42 expressing fly 
brains was significantly increased, when the gut microbiome was disturbed by colonization of non-
pathogenic enterobacteria. Similar effects had been previously seen with antibiotic induced gut 
microbiome in the Alzheimer’s disease murine model (Minter et al., 2016), which strengthens the 
hypothesis of the role of gut dysbiosis in the disease progression and gives credibility for the use of 
Drosophila as a dysbiosis model.   
Dysbiosis related diseases are a result of a complicated microbe-microbe and microbe-host 
relationships that pose a challenge for researchers as it is nearly impossible to take all the variables 
into account. One of the solutions for this problem, has been establishment of gnotobiotic, or in 
other words germ-free, animal models (Mooser, Gomez de Agüero and Ganal-Vonarburg, 2018). 
These models aim to minimise the randomness in datasets while still exploring the complex web of 
interactions. Zebrafish is one of the animals, in which a gnotobiotic research model has been 
established (Wang et al., 2018) and it has been used to study microbial colonization, for example.  
The above-mentioned examples illustrate that it is not only possible to model dysbiosis in 
taxonomically distant species, but that these models also provide valuable information as 
systematic clinical dysbiosis experiments with human patients are not possible.  
 
3.3 Choice of methods 
The methods used in this project have been widely used in the microbiome studies. This whole field 
of science is still relatively new and in practice emerged from the development of an easy and 
accessible sequencing technologies that could be used for the taxonomic classification of multiple 
species and samples in a single sequencing run. Thus, until recently most of the studies had been 
performed with a comparatively limited set of techniques that formed the golden standards of the 
field. Sequencing library is a pool of barcoded DNA fragments from different samples, which are 
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tagged with sequencing adapters. Library creation per se is the key to a successful sequencing run, 
as it determines the quality of reads and the sequencing run in general. The sequencing run itself 
requires little input from the researcher and is fully automated after the sample library is loaded 
into a machine and until the reads are generated. In this chapter, the methods and tools of choice 
are discussed considering previously published studies, especially the use of zebrafish as a model 
organism and the selection of the sequencing technology. 
3.3.1  Zebrafish as a model organism 
Zebrafish has been used as a model organism since 1960’s and it has been gaining popularity during 
the past couple of decades, which can be seen in the increase of the number of publications in 
databases (Figure 2.) (Scopus, 2019). The zebrafish is a good model organism for several reasons. 
One of the advantages is the rapid reproduction that produces offspring in abundance (Lawrence, 
2007). Females are spawning eggs continuously after reaching maturity (Lawrence, 2007) and a 
single breeding session with only few  fish can produce hundreds of fertilized eggs. Eggs hatch a few 
days post fertilization (dpf) and the zebrafish reach maturity at around 3 months of age (Spence et 
al., 2007). Zebrafish is also easily genetically manipulated (Garcia, Noyes and Tanguay, 2016) using 
technologies such as the CRISPR-Cas9 for genome editing or morpholinos for gene knock-outs. 
Zebrafish larvae are not regulated by the legislature for research animals, thus a lot of research is 
carried out in the larval model. In Finland, the use of the zebrafish under the age of 7dpf does not 
1
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Figure 2. The number of publications in the Scopus database that has "zebrafish" in the title, abstract or in the keywords. 
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require permission, but experiments conducted with older zebrafish must be approved by an ethics 
committee. The use of zebrafish larvae is convenient also due to their innate lack of pigmented cells 
during the first days after fertilisation (Tobin, May and Wheeler, 2012). The transparency of the 
larvae makes it possible to follow the development of organs in real time, and the usage of 
fluorescent markers is not uncommon. It is possible to postpone the formation of pigment by 
exposing the larvae to 1-phenyl-2-thiourea (PTU) (Karlsson, von Hofsten and Olsson, 2001). In 
microbiome studies, the transparency of the larvae has been taken advantage of, by using 
fluorescently labelled microbes for studying the colonization of gut microbiota in real time (Wiles et 
al., 2016). 
One of the advantages over other non-mammalian model organisms is the immune system of the 
zebrafish, which includes both the innate and the adaptive arms of the immune defence (Tobin, 
May and Wheeler, 2012). Thus, the zebrafish immune system reminds the human immune system 
more than that of for example D. melanogaster, that solely relies on the innate immune defence 
against pathogens on innate immune cells (Parsons and Foley, 2016) 
3.3.2 The zebrafish in microbiome studies 
The zebrafish is not the obvious choice for conducting microbiome studies aiming to increase the 
understanding of human health. However, its gut microbiome has been first characterized using 16S 
sequencing in 2006 (Rawls et al., 2006), and the zebrafish has since been used to study for example 
the effect of environmental anti-microbial agents for the gut microbiota (Gaulke et al., 2016), and 
the bacterial colonization of gut (Wiles et al., 2016). These studies have demonstrated that even if 
the core microbiota is drastically different at the taxonomical level from the human microbiota, the 
nature of the interactions between microbial species and between the microbes and the host, 
follows general patterns that are evident throughout the biosphere.  
It could be argued that zebrafish grown in a clean laboratory environment cannot be compared to 
individuals living in their natural habitat, and that this decreases their suitability for microbial 
ecology studies. This assumption was demonstrated to be false, as the core gut microbiota is 
strikingly similar between populations from five different zebrafish research facility and a wild 
population (Rawls et al., 2006). This finding suggests that it is possible to use laboratory-grown 
zebrafish in microbiome studies.  
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3.3.3 16S sequencing 
The small ribosomal subunit 16S RNA coding gene has provided microbiologist with an invaluable 
tool to characterize the species diversities of different bacterial environments (Klindworth et al., 
2013). The 16S gene is well suited for the purpose, since it has both highly variable regions and 
conserved regions that are relatively similar across the bacterial kingdom (Van de Peer, Chapelle 
and De Wachter, 1996). By using primers targeting the conserved regions that are flanking the more 
variable regions, researchers can multiply and sequence the region in between (D’Amore et al., 
2016). 16S gene have enough diversity and length to justify taxonomic characterization on a genus 
level based on the sequence (Callahan, McMurdie and Holmes, 2017), and it has been used for the 
purpose since  1985 (Pace et al., 1985). True potential of taxonomically characterizing microbes, was 
unleashed when the development of massive parallel sequencing techniques lowered the cost of 
sequencing per base to fit to a budget of a medium sized research group (Klindworth et al., 2013). 
This led to the establishment of a new field of science that studies the microbial environment as a 
complex system.  
The whole 16S gene is approximately 1500bp long, and therefore the most common sequencing 
technologies used for the purpose are not capable of sequencing the whole gene with single read. 
There are nine different variable regions in the gene; V1-V9 (D’Amore et al., 2016) which allows 
selecting suitable sized fragment for each technology. The most common region to be sequenced 
with the Illumina MiSeq sequencer (Illumina Inc., San Diego, California, USA), is the V3-V4 region 
between bases 341 and 806 (Zheng et al., 2015), which totals a fragment of 465bp. This fragment is 
frequently selected since the single primer pair is able to  target a large proportion of the bacterial 
species listed in SILVA database of microbial rRNA genes (Yilmaz et al., 2014).  
3.3.4 lllumina MiSeq 
Due to its availability and affordability, the Illumina Miseq has been a widely used sequencing 
technology for 16S sequencing since its introduction in 2011. The technology allows multiple reads 
to be sequenced simultaneously in a single flow cell without the need of cloning fragments into 
prokaryote cells (Mardis, 2013). The technology relies on so called sequencing by synthesis, which 
uses reversible dye terminators in the growing DNA strand to determine the incorporated 
nucleotide (Bentley et al., 2008).  
This chapter summarizes the core concepts of the Illumina MiSeq sequencing technology, as 
described by Bentley et al., (2008). On the sequencing flow cell, library DNA fragments are annealed 
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to adapter sequences conjugated onto the surface of the flow cell. These fragments are then 
amplified into clusters using bridge PCR, which is a type of PCR that utilizes surface conjugated DNA 
adapter sequences for binding library molecules onto the flow cell and keeping them spatially 
organized while multiplying the sequence. When these fragments are amplified, they form distinct 
and separated clusters of around 1 µm in diameter containing only copies of a single DNA sequence. 
After cluster generation, the orientation of the reads is made uniform by enzymatically cleaving the 
reads oriented in opposite direction. The sequencing occurs by synthesizing the new strand by 
incorporating fluorophore coupled 3’-O-azidomethyl 2’-deoxynucleoside triphosphates into the 
growing sequence. Fluorophores are excitated with lasers and the whole flow cell is then imaged. 
Tris(2-carboxyethyl) phosphine is used to remove the fluorophores from the incorporated 
nucleotides and to recover the 3’ OH-group for the next round of synthesis. It is possible to increase 
the sequence length by using paired end sequencing, where the fragment is first sequenced in one 
direction, flipped to another orientation and sequenced again. This decreases the drop in quality as 
the sequencing results in a longer overall read length while the overlaps are merged in data analysis.   
3.3.5 Data analysis; OTUs versus ASVs 
The sequencing data from Illumina MiSeq paired end sequencing is stored in two paired Fastq files 
that contains sequences and respective quality information of each sequenced base (Schloss et al., 
2009). The sequencing parameters can be set to organize the data from each sample into own 
folders, which eases the division of the reads to correct samples during later steps. For the analysis, 
the sequence data is stripped of the adapter and index sequences and the order of the sequence in 
these two paired files correspond to the location in a flow cell, which allows the merging of reads in 
downstream analysis (Callahan et al., 2016).     
The first standard and still a widely used method for 16S data processing has been to compare the 
sequence data together to map the reads into clusters of similar sequences using algorithms such 
as Mothur (Schloss et al., 2009) or UPARSE (Edgar, 2013). By selecting the threshold for maximum 
differences, these reads are clustered into groups of closely related sequences, so called Operational 
Taxonomic Units that should not be confused with species. These OTUs are then compared to 
databases such as SILVA (Yilmaz et al., 2014) or Greengenes (DeSantis et al., 2006) to make a 
taxonomic annotation for the data. (Schloss et al., 2009; Edgar, 2013; Callahan et al., 2016) The 
stricter the threshold, the better resolution the method gives, yet lowering the abundance of reads 
in a single unit, whereas a broader threshold lowers the resolution and increases the reliability 
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(Edgar, 2018). However, a recently published article speculates, whether the universally accepted 
97% threshold is out-dated as the databases have improved due to the increase in the amount and 
the quality of data (Edgar, 2018) This approach relies on taxonomic characterizations for the depth 
of sequencing in a given data set as OTUs are not constructed in relation to previous data sets, thus 
annotations can be reliably done on a rather general level (Callahan, McMurdie and Holmes, 2017). 
Another method for classification is to divide the sequencing reads into so called Amplicon 
Sequence Variants (ASV) (Callahan, McMurdie and Holmes, 2017). This approach differs from the 
OTUs in that reads are not clustered into groups of similar sequences, but each variant is dealt as 
an individual entity (Rosen et al., 2012).The rationale behind this approach is much better resolution 
since as the knowledge of the species and sequence data accumulates, these ASVs can be compared 
to existing data in the databases. This makes it possible to compare data between different 
sequencing runs in a way the OTUs could not, as the OTUs are defined again in each data set.   
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4 AIMS OF THE STUDY 
Aim of my master’s thesis project was to assess the suitability of the use of zebrafish as a model 
organism for oral microbiota and its dysbiosis. There are ambitions to find versatile and cost-
effective model for screening of treatment strategies for the microbial dysbiosis in oral 
environment, and for that purpose zebrafish is promising candidate. The main goal of this project 
was to find suitable methods for sample collection from the zebrafish oral and gut microbiotas, DNA 
extraction of small sample volume, an efficient library creation method, and optimize these 
methods into efficient protocol that can be used for future studies. Secondary goal was to 
characterise the oral and gut microbiotas.   
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5 MATERIALS AND METHODS 
The samples were collected from healthy adult female zebrafish from wild type population. 
Zebrafish in this study were grown in Zebrafish Core Facility of Tampere University (Faculty of 
Medicine and Health Technology), according to the laws and regulations for ethical treatment of 
laboratory animals. To avoid pain, which the sampling methods could inflict, the fish were 
euthanized in overdose of anaesthetic tricaine methanesulfonate before any samples were 
collected. All the experiments in this study were conducted implementing 3R principles, by using as 
few individual animals as possible without reducing quality of results. Guidelines for euthanasia and 
minimizing the production of unnecessary stress for the laboratory animals were followed through 
the study.  
5.1 Sample Collection 
Samples from zebrafish skin were collected by scraping with sterile scalpel and transferring the 
mucous secretion into bead beating tube. For collection of oral sample, the fish was embedded into 
foamed plastic bed and the sample was collected using sterile interdental brush. Bristles of the 
brush was cut into bead beating tube. The gastrointestinal sample was collected by dissecting the 
fish with scalpel and transferring the whole gut into bead beating tube. All the samples were kept 
on dry ice until DNA extraction. Each sample was given code, which was describing which sample 
set it was from, the anatomic location of the sample i.e. gut or mouth, and fish identifier. For 
example, gut sample from fish number six of sixth sample set is named 6G-6.  
5.2 DNA extraction methods 
DNA extraction kits were tested to find method that preserves as much of the DNA sample as 
possible. Five extraction methods were used; phenol-chloroform extraction, QIAamp DNA Stool 
Mini kit (Qiagen, Hilden, Germany) and NucleoSpin DNA Stool (Macherey-Nagel, Düren, Germany) 
kit for gut samples and phenol-chloroform, PureLink Microbiome DNA Purification Kit (Thermo 
Fisher, Waltham, Massachusetts, USA), Quick-DNA Fungal/Bacterial Microprep Kit (Zymo Research 
Corporation, Irvine, California, USA), and QIAamp DNA Stool Mini kit for oral and skin samples. Every 
silica column-based DNA extraction kits were used following the protocols. 
5.2.1 Phenol-chloroform extraction 
Phenol-chloroform extractions were conducted according to the protocol by Zhu (2014). 1300µl of 
Tri-reagent (Molecular Research Center Inc., Cincinnati, Ohio, USA) was added to each bead beating 
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tube. To enhance the yield, bead beating of 3000 rpm for 1:30 minutes with PowerLyzer 24 
homogenizer (Qiagen, Hilden, Germany) was performed twice. Samples were then sonicated in 
water bath for 9 minutes to also break the gram-negative bacteria. After these initial steps the phase 
separation was performed, and the DNA was eluted to 50 µl of sterile Milli-Q water. 
5.2.2 Comparison of DNA extraction methods 
The DNA concentration was measured by UV absorbance with NanoDrop 2000 (Thermo Fisher, 
Waltham, Massachusetts, USA) instrument. The instrument was blanked for each sample with 
respective elution buffer and measuring was done using 1.5 µl of sample. Each droplet was read 
three times to calculate the mean. Mean was calculated to minimize possible variability caused by 
instrument and low sample concentration. 
5.3 Primer design 
Even though Illumina has its own Nextera XT DNA Library Prep Kit (Illumina Inc., San Diego, 
California, USA) for creating a sequencing library for its MiSeq sequencer, there are numerous 
alternative ways reported in the literature (Fadrosh et al., 2014; Zheng et al., 2015). Each of the 
approaches has their own advantages and disadvantages, but common nominator is usage of PCR 
for attaching the sequencing adapters for the target sequence. Main reasons for the existence of 
multitude of approaches is arguably in the costs of the Illumina kits and the rigidity of the protocol. 
Alternative sequencing library protocols allow creating a library from thousands of samples for the 
same price as the Illumina Library Preparation kit for 24 samples costs.  
Sequencing library primers consists of multiple functional parts (Table 1.) First part from 5’ to 3’ are 
the adapter sequences. Adapters are essential for the sequencing reaction, as they are used to 
generate the clusters by attaching the library molecules to the sequencing flow cell (Bentley et al., 
2008). There are two different adapter sequences to ensure that all the sequencing reactions within 
cluster happens to the same direction. Next part is 8 nt long index sequence, which is required for 
multiplexing of samples in one sequencing run. Every sample is amplified using unique pair of index 
Table 1. Library PCR primer design. First parts are the P7 and P5 sequences, that are used to attach libraries to the flow cell during 
sequencing, then comes 8 nt long barcode sequence, which are used to identify sequences from different samples in multiplex PCR, 
pad sequences are for sequencing primer attachment, spacer is 0-3 nt long sequence that reduces homogeneity while sequencing 
highly conserved 16S gene, linker is selected to be as dissimilar to sequence before targeted gene region and the last portion of the 
primers are complementary to the targeted gene region. 
P7 seq i7 pad Spacer linker Rev primer
CAAGCAGAAGACGGCATACGAGAT TAAGGCGA GCAGGTCGGTCGGTCGACCG TGA CA GGACTACHVGGGTWTCTAAT
P5 seq i5 pad Spacer linker Fwd primer
AATGATACGGCGACCACCGAGATCTACAC CTCTCTAT CGTAGCCTGCCTCCGGTGAGG GAC TG CCTACGGGAGGCAGCAG
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sequences, which allows for the sequencing reads to be identified and allocated to correct samples 
during the data processing. The same index sequences as in the official Illumina index kit were used 
in this project, since those are carefully selected to function in multiplexing when varied number of 
samples are used.  
Pad sequences are used to prime sequencing reaction by binding the sequencing primers after 
cluster formation. Pad sequence in P7 end of the library has dual function as it is also used for 
priming the i7 index. Tm of the library PCR primers are most easily modified by altering the pad 
sequence. 
Spacers are 0–3 nt long sequences designed to desynchronise the sequencing reaction while 
sequencing highly homogenous fragments, such as 16S gene (Fadrosh et al., 2014). Identifying 
nucleotides during sequencing is based on four fluorescence dyes, each excitated using different 
wavelength. To record each nucleotide, the flow cell is then excitated with all these different 
wavelengths and then imaged. In each sequencing cycle, these dyes should be represented in equal 
proportions to ensure that sequencer is able to resolve the signals. Using the spacer also decrease 
the need for PhiX library, which is homogeneity increasing sequencing library added to the final 
sequencing pool.   
Linker sequence is a pair of nucleotides that are selected based on the target sequence. Optimal 
linker has minimum complementarity to the target region, which allows it to sequester sequencing 
overhang from the target gene, thus enhancing the PCR amplification of libraries.  
Last part of the primer is approximately 20 nucleotides long and it is designed to be complementary 
to the target sequence. 
5.3.1 Testing of primer pairs 
16S region targeting primer sequences were designed with TestPrime function in SILVA database 
(Yilmaz et al., 2014). The function compares primer sequences from user input to the 16S sequences 
in the database and returns information of the matched sequences. The search results of the 
function can be fine-tuned by adjusting few parameters, including number of allowed miss-matches 
per primer. Function returns list of organisms which have 16S gene sequence matching the primer 
pair within user defined threshold and the percentage value of the species coverage. f341 (Muyzer, 
de Waal and Uitterlinden, 1993) forward primer and 806R (Caporaso et al., 2011) reverse primer, 
resulting in 465 bp fragment targeting V3-V4 regions, was selected based on the TestPrime function. 
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5.4 Library creation in single PCR run 
Every PCR reaction in this project was done using AccuPrime Pfx SuperMix (Thermo Fisher, Waltham, 
Massachusetts, USA). Other components and their respective concentrations varied between 
experiments as aim of these experiments were to find optimal conditions for the PCR. Evaluation of 
PCR amplification was made using agarose gel electrophoresis. 
5.4.1  Mycobacterium marinum culture for positive control 
A 1ul loop of cultured M. marinum from 7H10 agar dish with 10% OADC enrichment and 0.5%v/v 
glycerol was diluted into 10 ml of 7H9 medium, supplemented with 10% ADC enrichment, 0.2% 
tween80 and 0.2% v/v glycerol in 25 ml cell culture flask. The culture was grown in 28 °C for 3 days 
at dark without shaking. Then the optical density with 600 nm wavelength (OD600) was measured 
and culture diluted 1:10 to fresh 7H9 medium. After 2 days incubation OD600 was measured again 
to evaluate the bacterial concentration. M. marinum from 1 ml of liquid culture was collected by 
centrifugation at 10,000 g for 3 min and the bacterial pellet was resuspended and diluted into 
1:10000 of fresh 0.2 µm sterile filtered PBS solution. 
5.4.2 Annealing temperature optimization 
The annealing temperature was searched with temperature 
gradient PCR. The total volume of the reaction was 10 µl, of 
which 8.5 µl was AccuPrime Pfx SuperMix, 0.5 µl of forward and 
reverse primer, and 0.5 µl of the template DNA. The reaction 
conditions were as follows; initial denaturation in 95 °C for 2 
minutes after which 30 cycles of denaturation in 95 °C for 20 
seconds, annealing with annealing gradient from 54°C to 70°C for 
15 seconds, and extension in 72 °C for 5 minutes. The final 
extension was in 72 °C for 10 minutes. Same protocol was performed for gut samples and M. 
marinum control sample to assess the suitability of the positive control.  
5.5 Library creation in single PCR run with two annealing temperatures 
The adjustment of annealing temperature mid-run can be performed to increase the yield with 
marginal loss of specificity. When the annealing temperature is lowered for few initial rounds, the 
specificity is slightly decreased but the amplification is more effective. Therefore, the ratio of 
template to background DNA is elevated prior applying the higher annealing temperature, which 
leads to better efficiency of the reaction without sacrificing the specificity. 
95°C 2 min
95°C 20 sec
x 30 54 - 70°C 15 sec
72°C 5 min
72°C 10 min
4°C →
[ ]
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5.5.1 Annealing gradient experiment 
Different combinations of annealing temperatures were tested in two-dimensional temperature 
gradient PCR (Table 2.). In the experiment the first annealing temperature was aligned along the 
rows of the PCR plate and second annealing temperature along the columns. Due to the limitations 
of the machine, the plate had to be turned 90° between the switch of the annealing temperature. 
For this test two different runs were performed, another with sample collected from the oral cavity 
of the zebrafish and another from the extracted gut sample of the same individual. The PCR 
instrument was programmed to run following program: initial denaturation in 98 °C for 5 minutes, 
then 6 cycles of denaturation in 98 °C for 30 seconds, annealing in temperature gradient from 43.3 
°C to 47 °C for 30 seconds, extension in 72 °C for 2 minutes. Then the protocol was paused, and the 
plate turned 90° so that the temperature gradient was orthogonal compared to the first stage. Then 
protocol was immediately continued with 36 cycles of denaturation in 98 °C for 30 seconds, 
annealing gradient from 44.4 °C to 50 °C and extension in 72 °C for 2 minutes. Final extension is 
performed in 72 °C for 5 minutes. 
5.5.2 Additive PCR panel 
Multiplying the 16S library has proven to be difficult, possibly due to inhibitors in the remaining in 
the samples after extraction (Schrader et al., 2012). To overcome the effects of these PCR inhibitors, 
certain additives can be used to increase the reaction efficiency. In this PCR experiment, different 
combinations of these additives were used. The total reaction volume in each sample was 10 µl of 
which 7.5µl AccuPrime Pfx SuperMix, 0.5µl of each primer, 0.5µl of template and 1 µl of additives 
or sterile Milli-Q water. The table 3. visualises the configuration of the additive panel. The additives 
used in this experiment were DMSO (Thermo Fisher, Waltham, Massachusetts, USA) and formamide 
98°C 5 min
98°C 30 sec
x 6 43,3-47°C 30 sec
72°C 2 min
98°C 30 sec
x 35 44,4-50°C30 sec
72°C 2 min
72°C 5 min
4°C →
[ ]
[ ]
Table 2. Two- stage PCR annealing gradient panel. Each column represents one 1. stage annealing temperature and each row 2. 
stage annealing temperature. The program used is presented on the right. 
43,3°C    
44,4°C
44,6°C  
44,4°C
46,3°C  
44,4°C
47,0°C  
44,4°C
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49,0°C
47,0°C  
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(Thermo Fisher, Waltham, Massachusetts, USA). The run parameters were selected based on the 
previous PCR experiment. The initial denaturation was performed in 98 °C for 5 minutes, then 6 
cycles of denaturation in 98 °C for 30 seconds, annealing in 46 °C for 30 seconds and extension in 72 
°C for 2 minutes. Then the second stage was immediately performed by running 35 cycles of 
denaturing in 98 °C for 30 seconds, annealing in 50 °C for 30 seconds and extension in 72 °C for 2 
minutes. The final extension was performed in 72 °C for 5 minutes.  
 
5.6 Exonuclease treatment 
The libraries contained bright band of primers in agarose gel after the PCR. To get rid of this, the 
samples were treated with exonucleases. 5 µl of sample, 1 µl FastAP Alkaline phosphatase (Thermo 
Fisher, Waltham, Massachusetts, USA) and 0.5 µl of ExoI 5’-exonuclease (Thermo Fisher, Waltham, 
Massachusetts, USA). Reaction mix was first incubated in 37 °C for 15 minutes using Biometra 
TPersonal (Biometra, Göttingen, Germany) thermocycler, to activate the enzymes and then in 85 °C 
for 15 minutes to halt the enzymatic activity. As the initial tests with the recommended protocol did 
not give desired outcome, incubation time optimization test was performed. In the test, four 
different 37 °C incubation times were tested 0.5 h, 1 h, 1.5 h and 2 h, while the termination phase 
was kept constant.  
200 ng/µl 100 ng/µl 50 ng/µl 25 ng/µl
200 ng/µl, 5%DMSO 100 ng/µl, 5%DMSO 50 ng/µl, 5%DMSO 25 ng/µl, 5%DMSO
200 ng/µl, 10% DMSO 100 ng/µl, 10% DMSO 50 ng/µl, 10% DMSO 25 ng/µl, 10% DMSO
200 ng/µl, 1,25% formamide 100 ng/µl, 1,25% formamide 50 ng/µl, 1,25% formamide 25 ng/µl, 1,25% formamide
200 ng/µl, 2,5% formamide 100 ng/µl, 2,5% formamide 50 ng/µl, 2,5% formamide 25 ng/µl, 2,5% formamide
200 ng/µl, 5% formamide 100 ng/µl, 5% formamide 50 ng/µl, 5% formamide 25 ng/µl, 5% formamide
Oral DNA Oral DNA, 1,25% formamide Oral DNA, 2,5% formamide Oral DNA, 5% formamide
Oral DNA, 5% DMSO Oral DNA, 10% DMSO Water No primers
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Table 3. Additive PCR panel. First six rows represent gut samples with different concentrations of template DNA and additives. Last 
two rows are for oral DNA and additives, and negative controls. 
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5.7 Nextera XT Library Preparation Kit 
The extracted zebrafish oral and gastrointestinal DNA of ten fish, were preamplified using 
AccuPrime Pfx SuperMix, F341_NeXT forward primer and 806R_NeXT reverse primer with Nextera 
tagmentation overhang sequences (Table 4.). For the reaction mix, 17µl of AccuPrime Pfx SuperMix, 
1 µl of 4 µM forward primer, 1 µl of 4 µM reverse primer and 1 µl of DNA template were mixed to 
total volume of 20 µl.  The initial denaturation was performed in 95°C for 5 minutes and then 25 
cycles of the denaturation in 95°C for 30 seconds, the annealing in 47°C for 30 seconds and the 
extension in 72°C for 2 minutes. The final extension in 72°C was 5 minutes.  
5.7.1 AMPure XP Bead purification 
AMPure XP Beads (Beckman-Coulter, Brea, California, USA) can be used for the fragment size 
selection by altering the ratio between samples and the beads. The shorter the fragment, the more 
beads there must be compared to the sample.  As the amplified DNA fragment was approximately 
500 bp, the beads to sample ratio was 1.8, thus for 10µl of sample 18µl of AMPure XP Beads were 
used. The protocol was performed using PCR-strips and a magnetic stand for 1.5 ml microcentrifuge 
tubes, which was stripped from the microcentrifuge tube manifold.  Fresh 70% ethanol was 
prepared, and all the steps were performed as in the protocol. Final elution to 30µl of Milli-Q water 
was used instead of the 40µl, suggested by the protocol.   
5.7.2 Fragment analyzer 
To assess the success of the library preparation protocol, the DNA fragment lengths of the samples, 
were characterized by using Fragment Analyzer (Agilent Technologies, Santa Clara, California, USA) 
instrument by Agilent Technologies. The method is based on dsDNA intercalating fluorescent dye, 
which marks the DNA during gel separation (Agilent, 2019). This technique gives relatively good 
estimation of mass per fragment size and thus is invaluable tool for defining the loading 
concentration for final library pool before sequencing 
Table 4. Pre-amplification primers used for extracted DNA sample prior to Nextera XT Library Preparation protocol. Overhang 
sequence is used for enzymatic attachment of sequencing adapters during Nextera XT protocol tagmentation step. 
Tagmentation overhang 16S complementary sequence
F341_NeXT 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGAGGCAGCAG
R805_NeXT 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT
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The fragment analyser was used for defining size distribution of the DNA fragments in the 
sequencing libraries, by using the DNA NGS Standard sensitivity kit. The reagents were thawing for 
at least 30 minutes before running the analysis. The separation gel was prepared by mixing 1µl of 
intercalating dye to 10ml of separation gel per row of samples. Capillary conditioning solution is 
prepared from the 5x stock solution by mixing 50 ml of the stock to 200 ml of Milli-Q water. Inlet 
buffer is diluted by mixing 50 ml of 5x stock solution to 200 ml of Milli-Q water. 1ml of this working 
solution is pipetted to each well of the first row of a MIDI storage plate, to replace the old inlet 
buffer in the machine. 100 µl of the rinse buffer is pipetted into the first row of wells of a semi-
skirted 96-well PCR plate. For each sample set, one row of semi-skirted 96-well PCR plate is filled 
with 22 µl of NGS diluent marker solution. 2 µl of NGS Standard sensitivity Ladder is pipetted to 
position 12 and 2 µl of samples to positions 1-11, any position that does not have sample is filled 
with 24 µl of specific blank solution. Before starting the analysis, the software of the machine was 
used to set the run parameters and naming the samples. After the run, data was ready to be 
exported to various data formats.  
 
5.8 Sequencing 
5.8.1 Library pooling 
For the pooling, loading concentrations needed to be normalized to 4 nM to ensure equal 
representation of different samples. The concentrations from the fragment analyser were used for 
calculating the loading volume for the final library pool. For total volume of 100 µl amount of each 
library was calculated with the following formula:  
Library volume =  
Final volume ×  final concentration
Number of pooled libraries ×  concentration of pooled library
 
The rest of the volume was filled with low-TE buffer.  
5.8.2 Denaturation of library and PhiX control 
For the denaturation, 1 ml of 0.2N NaOH was prepared from the 1.0 N NaOH stock solution by 
diluting it to the Milli-Q water. 5 µl of the normalized library pool was mixed with 5 µl of 0.2 N NaOH 
and incubated in RT for 5 minutes, after which 990µl of chilled HT1 buffer from the kit was mixed to 
halt the denaturation and dilute the library to 20 pM. As 6 pM was the desired final concentration, 
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20 pM library pool was further diluted by adding 420 µl of chilled HT1 buffer to 180 µl of library 
pool.  
PhiX control was next diluted to compensate for the homogeneity of sequencing 16S gene. 2 µl of 
20 nM PhiX control and 3 µl of 20 mM Tris-Cl pH 8.5 + 0.1 % Tween 20 was mixed. Then the PhiX 
was denatured by adding 5 µl of 0.2 N NaOH and incubating 5 minutes in room temperature. 990 
ml of chilled HT1 is added to stop denaturation and diluting the PhiX control to 20 pM. PhiX is further 
diluted to 12.5 pM by mixing 225 µl of chilled HT1 into 375 µl 20 pM PhiX. 
5.8.3 Sequencing run 
The sample sheet was created by using the Illumina Experiment Manager Software. With the 
software the index sequences were connected to the correct samples, serial numbers of the 
reagents and the sequencing cartridge was documented and the parameters for the run was 
selected. The 251 bp paired end sequencing was set to be the sequencing run length and the data 
format was set to FASTQ with adapter trimming applied. Once the sample sheet was created and 
carefully inspected, it was loaded into sequencing machine.  
5.8.4 Preparation of sequencing run 
The reagent cartridge was thawed in room temperature water bath for an hour before the loading 
of the denatured library pool.  Once thawed, reagents were mixed by inversions of the cartridge. By 
tapping the cartridge to benchtop, possible air bubbles were removed from the wells. Cartridge was 
kept on ice until used. The foil seal of the load sample well was pierced with sterilized 1 ml pipette 
tip and 600 ml of pooled and denatured library was pipetted in. The flow cell was taken from the 
storage buffer with plastic forceps and thoroughly rinsed with Milli-Q water to remove excess salts. 
To avoid scratching the surface of the flow cell, rinse water was carefully dried with lint-free lens 
cleaning tissues. Storage flow cell in the sequencing machine was replaced with rinsed and dried 
flow cell. In the sequencing machine, wash bottle was replaced by PR2 buffer solution and the waste 
bottle was emptied. Next the sequencing cartridge was loaded into the machine. 
 
5.9 Sequencing data analysis 
Data-analysis steps was performed with dedicated R-packages, the filtering and merging of paired 
end reads were done with DADA2 package (Callahan et al., 2016) and the visualization of the data 
with phyloseq package (McMurdie and Holmes, 2013). The data after sequencing was organized 
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into folders, which each contained reads for one sample stored in two FASTQ files, one for forward 
reads and another for reverse reads. These FASTQ files contained both the nucleic acid sequence 
data, already trimmed of the primer sequences, and the quality information.  
5.9.1 DADA2  
In the DADA2 pipeline, first step was to assess the quality of the reads with inbuilt quality 
assessment algorithm, which visualises the quality data by drawing a plot. Based on this information, 
the reads were then truncated to suitable length by cropping the poor-quality positions out of the 
data. In the same filtering step, the threshold for maximum number of erroneous bases for each 
read was set. The filtering parameters used for cropping was 250 and 235 bp for forward and reverse 
reads respectively, and the error threshold was set to maximum of two errors per read.  
Next, the machine learning algorithm was used to learn about the error rates in the sample set. The 
error rate information was used for combining copies of unique sequences into one, while 
maintaining the quality data. This dereplication phase greatly reduces the required computing 
power in downstream analysis. DADA2 algorithm differs from other dereplication methods, by 
combining the quality data of each copy of a unique read into the dereplicated sequence. Preserving 
the quality data improves the reliability of the data analysis, as sequence variants can be compared 
and assessed whether the difference between two closely related variants are truly different and 
not artefact of the PCR or another phase of the library preparation. 
After the dereplication, paired end reads were merged to form full length sequences. The read pairs, 
which did not align properly were discarded. The merged sequences are then arranged into ASV 
table, which was later used for searching database for matching sequences. First ASVs were filtered 
for primer dimers that may have occurred during the library creation. 16S genes have some 
variations in length, but when sequence length is significantly beyond normal range it was justified 
to consider such a sequence as an artefact.  Before the taxonomic annotation of the ASVs, the 
sequences can be filtered based on the sequence length thus removing the artefacts from the 
sample set. 
5.9.2 Phyloseq 
Phyloseq package for R is flexible tool that uses ggplot2 graphics package for visualization of 
microbial data. It can be used for turning the ASV table into easily readable publication ready graphs 
and visualizations of the data. Reasonable way to illustrate 16S data is to assess the microbial 
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diversity in studied environment by plotting rarefaction curves and alpha diversities. These plots are 
easily visualized as the variables are already in the memory after previous analysis phases. Alpha 
diversity is important metrics for diversity assessment in the studied microbial environment, 
depending on equation used, it measures how rich the variety of species exist in the sample and 
how evenly they are spread. Shannon index takes both, number of species and their relative 
abundances into account when calculating the alpha diversity value. The Index is calculated with 
following formula:  
𝐻 = − ∑ 𝑝𝑖 𝑙𝑛𝑝𝑖
𝑠
𝑖=1
 
Where pi is the number of observed members of certain ASV divided by number of total members 
of all ASVs in the sample. The pi is then multiplied by its own natural logarithm, this calculation is 
repeated for all unique ASVs and results are summed together. The diversity index achieved by 
multiplying the sum by -1.  
5.9.3 VEGAN 
The assessment of sequencing depth was done using Vegan R-package (Dixon, 2003). The 
rarecurve() function was used to draw rarefaction curve. The function goes through reads one at a 
time and cumulatively tracks the encountered new unique reads. The resulting figure shows 
whether the sequencing depth was enough for revealing all the different ASVs in the sample, if the 
curve plateaus, there were enough sequencing reads to cover the whole diversity.   
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6 RESULTS 
6.1 Extraction methods 
6.1.1 Oral samples 
The oral microbial DNA were extracted using four different methods. In figure 3. DNA yields 
determined from UV-absorbance readings measured with NanoDrop 2000 instrument, were 
compared in a boxplot. As the elution volume differed between extraction sets, the chart portrays 
the yield as total mass of DNA instead of concentration.  
Highest yields from single samples were acquired with phenol-chloroform extraction (n = 8, median 
= 669 ng), although there were lot of deviation between samples. From silica column-based 
methods PureLink Microbiome DNA Purification Kit was used the most and resulted in relatively 
good and consistent yields (n = 27, median = 985 ng). Quick-DNA Fungal/Bacterial Microprep kit (n 
= 8, median = 79 ng) and QIAamp DNA Stool Mini Kit (n = 4, median = 121.25 ng) produced lowest 
yields of tested methods, but the sample sizes were also small.    
6.1.2 Gut samples 
Gut microbial DNA extraction methods were compared (Figure 4.) to find most effective method to 
purify DNA for downstream analysis. Concentrations were calculated from UV-absorbances 
measured with NanoDrop 2000 instrument. Three methods were used, phenol-chloroform 
Figure 3. Oral sample DNA yields. Zebrafish oral microbial DNA sample total DNA yields drawn as boxplot figure. Four 
different extraction methods were tested, and their effectiveness were evaluated by measuring the total DNA by calculating 
concentrations from UV-absorbance readings measured by NanoDrop 2000 instrument. PureLink Microbiome DNA 
Purification Kit (n = 27, median = 985 ng), Quick-DNA Fungal/Bacterial Microprep kit (n = 8, median = 79 ng), QIAamp DNA 
Stool Mini Kit (n = 4, median = 121.25 ng) and phenol-chloroform extraction (n = 8, median = 669 ng) were the methods used. 
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extraction (n = 8, median =13000 ng), NucleoSpin DNA Stool Kit (n = 20, median =4037.5 ng) and 
QIAamp DNA Stool Mini Kit (n = 12, median = 16375 ng).  QIAamp DNA Stool Mini Kit produced the 
best yields of tested methods, although the deviation was relatively high. The phenol-chloroform 
extraction yields were lower than the QIAamp kit, although being more consistent between 
samples. The NucleoSpin DNA Stool Kit produced relatively consistent results while yields were 
lower than with the other methods. 
  
6.2 Library creation in single PCR run 
16S sequencing library PCR conditions were 
optimized in annealing temperature gradient 
PCR, by using M. marinum DNA as a template 
(Figure 5.). Annealing temperatures ranged from 
54 °C to 70 °C. 64.1 °C was the highest 
temperature where 16S band was visible in a gel 
electrophoresis and all temperatures lower than 
that had intense band. Results were not 
reproducible with sample DNA.  
Figure 4. Gut sample DNA yields. Three different methods for zebrafish gut microbiome DNA sample extraction were piloted 
throughout the study. Total DNA yields from each method are portrayed in this boxplot. Y-axis is the mass of the total DNA in 
nanograms and DNA from each method are shown in their respective figures.  NucleoSpin DNA Stool Kit (n = 20, median 
=4037.5 ng), QIAamp DNA Stool Mini Kit (n = 12, median = 16375 ng) and phenol-chloroform extraction (n = 8, median =13000 
ng were the methods used). 
Figure 5. Gel electrophoresis of PCR amplified 16S gene 
of M. marinum. PCR protocol was optimized for 
annealing temperature, which are shown on top of the 
image. Annealing temperature greatly affects the 16S 
DNA multiplication efficiency. Band intensity is elevated 
towards lower temperatures as is expected.  
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6.3 Library creation in single PCR run with two annealing temperatures 
6.3.1 Annealing gradient experiment 
P PCR protocol with two different annealing temperatures was used to increase specificity and yield 
of PCR reaction. DNA samples from the zebrafish oral cavity and gut were used as templates in an 
experiment where aim was to find suitable combination of first and second annealing temperature 
(Figure 6.). In the oral samples the 16S gene was more effectively amplified than in the gut samples. 
Noticeable increase in the amplification can be seen when the second annealing temperature was 
decreased from 50 °C to 49°C. Also, when first stage annealing temperature was decreased, the 
band intensity was slightly increased. Similar trends could be seen in the gut samples, where the 
overall band intensity was significantly lower, and reaction appeared to be less specific, indicated 
by an unknown second band approximately at 350bp.  
6.3.2 Applying protocol for sample set 
Based on the previous experiment, the annealing temperatures were selected for the protocol that 
was used for five oral and skin DNA samples. The protocol produced visible bands in the gel 
electrophoresis in all but one individual oral sample (Figure 7.). Band intensities, however, varied 
among the samples that had successfully amplified the 16S gene. Skin samples had lower rate of 
success than oral samples. One of skin samples had similar bands to the ones present in gut samples 
Figure 6. Gel electrophoresis of two phase annealing gradient PCR experiment. Combinations of first and second stage annealing 
temperatures were tested in single PCR experiment. Each cluster of four bands represents the second annealing temperature in 
decreasing order and inside the clusters are the first annealing temperatures in increasing order. Upper image is from oral microbial 
samples and lower from the gut samples. 
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in previous experiment including a visible smear of the contaminating background DNA. Another 
sample did show similar behaviour with barely visible bands. One sample represented more of the 
oral sample in that it had only one band around 500bp. It was faint enough to not be considered as 
a success.    
6.3.3 PCR additive panel 
For enhancing the effectivity of PCR protocol for the gut samples, different PCR additives were 
tested in variety of concentrations and combinations. However, no 16S DNA bands were visible in 
the resulting gel electrophoresis except two oral samples that had one clear band at around 500bp 
6.4 Exonuclease treatment 
For primer removal from the PCR amplified samples, exonuclease treatment with exonuclease I and 
FastAP alkaline phosphatase was tested with 0,5 h; 1 h; 1,5 h and 2 h treatment time. None of the 
tested times were enough to reduce the amount of primers in sample, when visually inspected after 
gel electrophoresis.    
6.5 Illumina library kit 
6.5.1 16S pre-amplification with PCR 
Illumina protocol begun with pre-amplification PCR of 16S V3-V4 region. Sequence specific primers 
were attached to 20 nucleotides long overhang sequences, designed for sequencing adapter 
tagmentation in later phases of library preparation. Optimized PCR conditions from previous 
experiments were utilized when the program was designed.  All the samples had amplified the 16S 
sequence, yet in the oral samples the DNA bands were faint and nearly non-distinguishable (Figure 
8.). Gut samples had more intense bands in each sample and more non-specific background. All 
three negative control samples did not show any visible DNA band, whereas M. marinum positive 
control had intense band at 500 bp.  
Figure 7. Gel electrophoresis of the zebrafish oral and skin microbial sample DNA. 16S gene amplified with PCR. Using the conditions 
optimized during the previous experiment the resulting program was tested with larger sample set.   
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6.5.2 Fragment analyser 
The first round of fragment analysis was performed for all the samples that had been used through 
library preparation protocol. As an output, the instrument draws a graph of the emitted 
fluorescence, emission intensity on y-axis in relative fluorescence units and fragment length in base 
pairs on x-axis. The program also gives the mass of each peak calculated from the peak surface area. 
Figure 9. is the fragment analyser graph of gut sample 6G-8, after the gel extraction. 
Figure 9. Fragment analyzer fluorescence intensity curve. Gut sample 6G-8 measured with fragment analyser. 1 bp marker is named 
as LM and 6000 bp marker as UM. The highest peak at 603 bp is the amplified 16S library. Some non-insignificant amount of 
contaminating DNA is present in samples, which led to gel extraction purification step 
Figure 8. Limited cycle pre-amplification PCR. Zebrafish oral and gut microbial sample DNA was amplified with sequencing adapter 
conjugated 16S primers. All the samples have at the very least faint band of 16S DNA amplified in the gel 
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6.5.3 Gel extraction of library fragments 
As the samples contained lot of noise in addition to the library fragment, the samples had to be 
purified running the samples to agarose gel and extracting the 16S bands with GeneJet Gel 
Purification Kit (Figure 10.).  The number of samples was decreased from 20 to 6 as most of the 
samples had insufficient amount of amplified 16S library after the gel extraction.  
Figure 10. Gel extraction of 16S libraries. As the sample purity of amplified 16S libraries was not satisfactory, gel extraction of the 
samples with highest yield was performed. Number of samples was lowered from 20 to 6 samples and the controls. Each sample was 
divided into two wells due to high volume. 
Figure 11. Fragment analysis of gel extracted 16S library. After the gel extraction step most of the impurities are successfully removed 
from the sample. The sample shown here is the 6G-8. 
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6.5.4 Fragment analysis of purified samples 
When the library fragments were purified, the fragment analysis was run. The resulting graph of gut 
sample 6G-8 can be seen in figure 11. Most of the impurities were removed in gel extraction 
according to fragment analysis results. However substantial amount of library fragment was also 
lost in the purification step.  
6.6 Sequencing data 
6.6.1 DADA2 
Sequences were filtered in multiple steps to remove the sequencing artefacts from the reads. The 
table 5. shows how much each filtering step reduced the number of reads.  The mean number of 
reads per sample before the filtering were approximately 121,000 reads. The first filtering step had 
considerable effect on the number of reads, as approximately 20% of the reads were discarded. 
Denoising and merging of paired reads had only limited effect on for total number of reads. Chimera 
6G-10 70812 (100) 58919 (83,2) 58757 (83,0) 58713 (82,9) 57894 (81,8) 43644 (61,6)
6G-6 98530 (100) 76418 (77,6) 75431 (76,6) 74501 (75,6) 72971 (74,1) 41538 (42,2)
6G-8 122847 (100) 102970 (83,8) 102670 (83,6) 102558 (83,5) 101794 (82,9) 75260 (61,3)
6M-10 154335 (100) 129715 (84,0) 128739 (83,4) 128551 (83,3) 127353 (82,5) 93127 (60,3)
6M-6 126814 (100) 101303 (79,9) 98867 (78,0) 97234 (76,7) 93686 (73,9) 49668 (39,2)
6M-8 154886 (100) 128808 (83,2) 128208 (82,8) 127682 (82,4) 126596 (81,7) 91472 (59,1)
CTRLneg 1223 (100) 734 (60,0) 678 (55,4) 624 (51,0) 557 (45,5) 524 (42,8)
CTRLpos 110130 (100) 87700 (79,6) 87634 (79,6) 87582 (79,5) 87223 (79,2) 65781 (59,7)
Input Filtered DenoisedF DenoisedR Merged Nonchim
Table 5. Number of reads per sample after each filtering step. Samples which are marked as “6G” refers to gut samples and “6M” 
refers to oral samples, numbers in the sample names are identifiers for individual fish. 
Figure 12. Rarefaction curve and measured alpha diversities in samples.  A. The sequencing depth is shown in rarefaction curve. Total 
reads in the x-axis and observed unique ASVs in y-axis B. Alpha diversity is presented here as function of Shannon diversity index. 
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removal discarded another 20% of the reads. After the filtering steps approximately 65,000 reads 
per sample or 53.3% of the reads in total were remaining. For assessing the sequencing depth, the 
rarefaction curve was drawn (Figure 12. A). All the samples do plateau in the curve, and therefore, 
the sequencing depth was sufficient to reveal the microbial diversity in the samples. 
6.6.2 Alpha diversity 
The first taxonomic characterisation for the samples was determining the alpha diversity values as 
a function of the Shannon index (Figure 12. B). Based on the index metrics, individual’s microbiomes 
were comparatively diverse in different anatomic locations, and microbiomes from the same 
individual clustered together in the graph. The Shannon diversity index also suggests that the gut 
microbiota was systematically slightly less diverse than the oral cavity microbiotas, although the 
sample size was too small to make definite conclusions. 6G-6 and 6M-6 appears to be distinctly 
more diverse when compared to the other samples.  
6.6.3  Most abundant microbes 
In the figure 13. the relative abundance of microbial orders is presented as percentage from total 
number of reads in sample that were annotated to the genus level and each order is coloured with 
variation of colour theme of the phyla it belongs to. Proteobacteria, Firmicutes and Actinobacteria 
were the most abundant phyla in the studied samples and most of the abundance was made up by 
Proteobacteria and Firmicutes. Considerable amount of Actinobacteria was only present in 
microbiotas of fish where Propionibacteria was the most common. Most of Proteobacteria belongs 
to order Aeromonadales and the rest of the phylum consists of rather tiny proportion of the reads. 
Oral cavity microbiota has more diversity within Proteobacteria than gut, except the 6G-6 and 6M-
6 which had distinct diversity in both environments and had oral microbiota, in which other orders 
of Proteobacteria made up roughly 40% of total reads. In the gut microbiota Firmicutes made up 
8%-27% of the reads, which made it the second largest phylum after Proteobacteria. In the oral 
environment Firmicutes was the most abundant except in the 6M-6. Most of the firmicutes belongs 
to the order Clostridiales, but Bacillales and Lactobacillales have also significant representation 
within many samples.  Even rare taxonomic groups, which only have few reads can be important for 
the functions of the microbiota. As these groups are easily buried when abundances are shown in 
absolute scale, in figure 14. microbial phyla are portrayed in logarithmic scale to reveal rare taxa. 
Some phyla such as Chlamydiae is present in nearly all samples, yet neither had even 100 reads for 
it and some were only present in just one or few samples. 
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Figure 13. Relative abundances of reads annotated for each microbial order. The chart combines all the reads that were annotated 
down to genus level and presents them as percentage of total reads in the sample. Taxonomic ranks are visualised so that each order 
belonging to same phylum are variations of the same colour theme 
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Acidobacteria - Blastocatellia - Blastocatellales
Actinobacteria - Acidimicrobiia - Acidimicrobiales
Actinobacteria - Actinobacteria - Streptosporangiales
Actinobacteria - Actinobacteria - Pseudonocardiales
Actinobacteria - Actinobacteria - Propionibacteriales
Actinobacteria - Actinobacteria - Micrococcales
Actinobacteria - Actinobacteria - Corynebacteriales
Actinobacteria - Actinobacteria - Bifidobacteriales
Actinobacteria - Actinobacteria - Actinomycetales
Bacteroidetes - Bacteroidia - Bacteroidales
Bacteroidetes - Cytophagia - Cytophagales
Bacteroidetes - Flavobacteriia - Flavobacteriales
Bacteroidetes - Sphingobacteriia - Sphingobacteriales
Chlamydiae - Chlamydiae - Chlamydiales
Chloroflexi - Chloroflexia - Chloroflexales
Euglenozoa - Euglenida - Aphagea
Firmicutes - Bacilli - Lactobacillales
Firmicutes - Bacilli - Bacillales
Firmicutes - Clostridia - Clostridiales
Firmicutes - Erysipelotrichia - Erysipelotrichales
Fusobacteria - Fusobacteriia - Fusobacteriales
Nitrospirae - Nitrospira - Nitrospirales
Planctomycetes - Planctomycetacia - Planctomycetales
Proteobacteria - Alphaproteobacteria - Sphingomonadales
Proteobacteria - Alphaproteobacteria - Rhodospirillales
Proteobacteria - Alphaproteobacteria - Rhodobacterales
Proteobacteria - Alphaproteobacteria - Rhizobiales
Proteobacteria - Alphaproteobacteria - Caulobacterales
Proteobacteria - Betaproteobacteria - Burkholderiales
Proteobacteria - Deltaproteobacteria - Myxococcales
Proteobacteria - Deltaproteobacteria - Desulfurellales
Proteobacteria - Gammaproteobacteria - Xanthomonadales
Proteobacteria - Gammaproteobacteria - Vibrionales
Proteobacteria - Gammaproteobacteria - Pseudomonadales
Proteobacteria - Gammaproteobacteria - Legionellales
Proteobacteria - Gammaproteobacteria - Enterobacteriales
Proteobacteria - Gammaproteobacteria - Alteromonadales
Proteobacteria - Gammaproteobacteria - Aeromonadales
Retaria - Foraminifera - Globothalamea
Figure 14. Microbial phyla in sequenced samples. The y-axis shows number of reads per phyla in logarithmic scale. 
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6.6.4 Genus level diversity 
In the table 6. 71 of the most common genera are organised in decreasing order the genera with 
the highest total number of reads in the top. The two most common genera were Paraclostridium 
and Aeromonas, present in high numbers in every samples. Previous figures and tables have shown 
6G-6 and 6M-6 to have distinct microbiota and this table confirms the observation. 6G-10 had in 
total 21 genera present in gut and 6M-10 had 25 genera in oral microbiota, where 6G-6 and 6M-6 
had 76 and 77, and 6G-8 and 6M-8 had 21 and 56 respectively. Every fish had more genera in oral 
environment, but number of species in total was significantly higher in 6M-6, which also had the 
number of reads more evenly spread between genera. In the genus level, some obvious differences 
could be observed when taxonomic ranks were inspected in the genus level. For example, number 
of Methylobacterium and Escherichia/Shigella were nearly ten times higher in oral samples than in 
gut. Another example being Burkholderia-Paraburkholderia which had abundant reads in oral 
samples but were not present in gut samples except in the 6G-6. One can also observe that gut 
microbiota had no genera which are abundant in gut but non-existent or only present in lower 
numbers in oral environment. The gut microbiota also seems to be less homogenous outside of the 
two most common genera that makes most of the reads. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 6. Most abundant genera of sequenced microbiome samples. Genera are organized to show highest total amount of reads in 
the top. Also, taxonomic ranks are shown up to the phylum level. Note that only reads annotated down to the genus level are shown 
in this table. 
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Phylum Class Order Family Genus 6G-10 6G-6 6G-8 6M-10 6M-6 6M-8
Firmicutes Clostridia Clostridiales Peptostreptococcac. Paraclostridium 2614 2124 19836 79333 2111 64922
Proteobacteria Gammaproteobact. Aeromonadales Aeromonadaceae Aeromonas 38693 16786 52649 8880 13603 15678
Proteobacteria Gammaproteobact. Xanthomonadales Xanthomonadaceae Stenotrophomon. 0 2808 21 0 3833 343
Proteobacteria Alphaproteobact. Rhizobiales Methylobacteriaceae Methylobacter. 40 1424 90 445 2188 717
Proteobacteria Gammaproteobact. Enterobacteriales Enterobacteriaceae Escherichia/Shig. 39 1420 0 366 1958 716
Actinobacteria Actinobacteria Propionibacteriales Nocardioidaceae Nocardioides 0 1571 0 0 2572 300
Proteobacteria Alphaproteobact. Rhodobacterales Rhodobacteraceae Paracoccus 4 1406 0 0 2392 364
Proteobacteria Gammaproteobact. Pseudomonadales Pseudomonadaceae Pseudomonas 0 763 299 2 1135 48
Proteobacteria Alphaproteobact. Sphingomonadales Sphingomonadaceae Sphingomonas 0 754 0 110 759 427
Proteobacteria Betaproteobacteria Burkholderiales Burkholderiaceae Burkholderia-Par. 0 499 0 274 721 308
Proteobacteria Betaproteobacteria Burkholderiales Alcaligenaceae Achromobacter 0 621 0 0 950 109
Firmicutes Bacilli Bacillales Bacillaceae Bacillus 66 421 59 265 454 332
Firmicutes Clostridia Clostridiales Peptostreptococcac. Peptostreptococ. 0 480 9 0 926 143
Actinobacteria Actinobacteria Corynebacteriales Mycobacteriaceae Mycobacterium 7 500 0 0 733 249
Firmicutes Bacilli Lactobacillales Enterococcaceae Vagococcus 219 355 0 0 413 252
Proteobacteria Alphaproteobact. Rhizobiales Rhizobiaceae Rhizobium 0 299 0 159 666 113
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 0 408 5 0 467 13
Firmicutes Clostridia Clostridiales Lachnospiraceae Epulopiscium 239 0 113 0 0 402
Firmicutes Clostridia Clostridiales Peptostreptococcac. Asaccharospora 0 271 0 0 350 69
Proteobacteria Alphaproteobact. Rhodobacterales Rhodobacteraceae Defluviimonas 0 184 16 0 386 0
Firmicutes Bacilli Lactobacillales Leuconostocaceae Weissella 0 181 0 6 280 117
Actinobacteria Actinobacteria Micrococcales Microbacteriaceae Microbacterium 0 122 7 0 278 147
Proteobacteria Alphaproteobact. Caulobacterales Caulobacteraceae Caulobacter 13 144 4 96 160 136
PlanctomycetesPlanctomycetacia Planctomycetales Planctomycetaceae Singulisphaera 0 192 0 0 295 0
Firmicutes Clostridia Clostridiales Family_XI Gallicola 0 217 0 0 218 9
PlanctomycetesPlanctomycetacia Planctomycetales Planctomycetaceae Gemmata 0 190 0 0 223 0
Firmicutes Clostridia Clostridiales Clostridiaceae_1 Clostridium sensu 0 192 0 0 125 62
Proteobacteria Alphaproteobact. Rhizobiales Methylobacteriaceae Meganema 0 138 0 37 161 36
Proteobacteria Betaproteobact. Burkholderiales Comamonadaceae Xylophilus 16 115 7 41 112 64
Bacteroidetes Sphingobacteriia Sphingobacteriales Chitinophagaceae Asinibacterium 0 149 0 47 117 27
Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 0 116 0 4 214 0
Proteobacteria Alphaproteobact. Rhodospirillales Rhodospirillales Inc. Reyranella 0 130 0 0 200 0
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus 5 106 0 0 152 64
Firmicutes Bacilli Lactobacillales Enterococcaceae Enterococcus 124 0 0 0 0 197
Firmicutes Bacilli Lactobacillales Carnobacteriaceae Carnobacterium 0 94 0 0 178 46
Firmicutes Clostridia Clostridiales Family_XI Tepidimicrobium 0 120 0 0 179 10
Actinobacteria Actinobacteria Pseudonocardiales Pseudonocardiaceae Pseudonocardia 0 158 2 0 146 0
Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae Actinomyces 0 138 0 0 153 0
Proteobacteria Alphaproteobact. Rhizobiales Phyllobacteriaceae Mesorhizobium 0 0 0 0 0 217
Proteobacteria Alphaproteobact. Rhizobiales Xanthobacteraceae Labrys 0 70 0 0 127 17
Firmicutes Clostridia Clostridiales Family_XI Peptoniphilus 7 130 0 0 44 29
Chloroflexi Chloroflexia Chloroflexales Chloroflexaceae Candidatus Chlor. 0 51 0 0 78 77
Bacteroidetes Sphingobacteriia Sphingobacteriales Chitinophagaceae Sediminibacter. 6 69 0 26 100 5
Firmicutes Clostridia Clostridiales Clostridiaceae_1 Clostridium sensu 2 53 4 25 76 39
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus 0 66 0 0 133 0
Proteobacteria Alphaproteobact. Rhizobiales Rhizobiales Inc. Phreatobacter 0 73 0 0 111 8
Bacteroidetes Cytophagia Cytophagales Cytophagaceae Spirosoma 0 69 0 0 105 0
Actinobacteria Actinobacteria Propionibacteriales Propionibacteriaceae Propionibacter. 0 49 0 5 81 35
Proteobacteria Alphaproteobact. Rhizobiales Phyllobacteriaceae Aminobacter 0 69 0 0 89 0
Actinobacteria Actinobacteria Micrococcales Micrococcaceae Rothia 0 59 0 0 86 10
Proteobacteria Gammaproteobact. Legionellales Legionellaceae Legionella 0 67 0 0 87 0
Firmicutes Clostridia Clostridiales Peptostreptococcac. Paeniclostridium 0 58 0 0 89 0
Firmicutes Clostridia Clostridiales Clostridiaceae_1 Hathewaya 0 60 0 0 85 0
Firmicutes Bacilli Bacillales Bacillaceae Anoxybacillus 0 70 0 0 73 0
Firmicutes Clostridia Clostridiales Clostridiaceae_1 Clostridium sensu 0 61 0 0 77 0
Proteobacteria Alphaproteobact. Rhodobacterales Rhodobacteraceae Albimonas 0 42 0 0 83 0
Chlamydiae Chlamydiae Chlamydiales Parachlamydiaceae Neochlamydia 5 9 4 0 30 74
Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae Aquabacterium 0 66 0 0 55 0
Proteobacteria Gammaproteobact. Legionellales Coxiellaceae Coxiella 0 0 0 0 120 0
Firmicutes Clostridia Clostridiales Peptostreptococcac. Proteocatella 0 53 0 0 65 0
Actinobacteria Actinobacteria Corynebacteriales Corynebacteriaceae Corynebacterium 0 44 0 0 44 23
Fusobacteria Fusobacteriia Fusobacteriales Fusobacteriaceae Fusobacterium 0 45 0 0 63 0
Actinobacteria Acidimicrobiia Acidimicrobiales Iamiaceae Iamia 0 34 0 0 72 0
Proteobacteria Alphaproteobact. Rhizobiales Bradyrhizobiaceae Bradyrhizobium 0 32 0 0 73 0
Firmicutes Bacilli Bacillales Planococcaceae Domibacillus 0 0 0 0 0 101
Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminiclostrid. 0 0 0 0 100 0
Firmicutes Erysipelotrichia Erysipelotrichales Erysipelotrichaceae Erysipelothrix 0 46 0 0 50 0
Proteobacteria Betaproteobact. Burkholderiales Burkholderiaceae Cupriavidus 0 0 0 0 0 93
Firmicutes Clostridia Clostridiales Family_XI Anaerococcus 0 47 0 0 40 0
Proteobacteria Deltaproteobact. Desulfurellales Desulfurellaceae H16 4 46 0 0 35 0
Firmicutes Bacilli Lactobacillales Leuconostocaceae Leuconostoc 0 20 0 0 57 0
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7 DISCUSSION 
The objective of the project was to characterize the oral microbiota of the healthy zebrafish and 
establish a protocol that can be used in further studies of microbe-microbe and microbe-host 
interactions in oral environment. In recent years, sequencing the ribosomal small subunit RNA 
coding gene variable regions, has been the prevalent method for microbial taxonomical 
classification (D’Amore et al., 2016), due to its low cost and an abundance of data it provides. 
Selecting this technique was easy choice as there are already wide selection of published papers, 
which use this technique in variety of different study settings, spanning from environmental to 
clinical samples (Caporaso et al., 2011; Byrd, Belkaid and Segre, 2018).  
 
7.1 Extraction methods 
As remarked earlier in this text, the oral samples from the zebrafish is challenging task. Volume in 
the mucous sample is diminishingly small and it also reflects in the DNA extraction step and all the 
other downstream workflows, while also affecting the UV-absorbance based measurements of 
concentration. As expected based on literature on the subject, phenol-chloroform extraction 
provided good yield in both sample types (Rosenbaum et al., 2019), although in oral samples there 
were substantial variation between individual samples. In silica column-based methods there is 
always lower DNA extraction yield (Rosenbaum et al., 2019), yet the purity and consistency between 
samples and swiftness of the protocols are considerable benefits that outweighs loss of yield 
compared to traditional phenol-chloroform extraction. Based on these experiments PureLink 
Microbiome DNA Purification Kit was selected for oral sample DNA extraction method for upcoming 
experiments. For gut samples QIAamp DNA Stool Mini Kit produced the best yield out of all methods 
but was unfortunately discontinued during the study. It was replaced by NucleoSpin DNA Stool Kit, 
which was the worst performing of the tested gut DNA extraction method measured in total DNA 
yield. However, it was still selected due to its fast and convenient protocol and yield that was enough 
for producing sequencing library. The PCR optimization in this thesis project was mainly for finding 
optimal conditions, but in hindsight it would have been interesting to compare DNA extracted with 
different methods for amplification efficiency. Now the only comparison was the total yield of DNA 
and not the quality of the DNA. 
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7.1.1 Optimizing the PCR protocol 
PCR as a technique is rather robust, although some samples do require laborious optimization to 
function properly, which was evident when working with zebrafish microbiome samples. The 
difficulties for multiplication of nucleic acid sequences may arise from multiple different factors. The 
primers might form dimers, secondary structures, or the Tm’s of the primer pair does not match 
each other. Sample can also have substances that inhibits the efficiency of the reaction (Schrader et 
al., 2012). It is not clear which factors contributed to the difficulty of finding suitable reaction 
conditions in this study. 
PCR is essential for successful sequencing run and there are numerous factors that can affect the 
outcome, potentially even obstructing the success of whole sequencing reaction.  Potential source 
of error for misidentifying reads is cross-contamination of library primers during purification steps 
of manufacturing process or later by the final user, which can potentially have drastic effect for the 
interpretation of the results. User have little influence over the manufacturing process of primers, 
so extra care should be taken during performing PCR and other library creation steps to have as 
pure library as possible. 
7.2 AccuPrime Pfx SuperMix 
From the literature different alternatives for PCR reagents were compared and AccuPrime Pfx 
SuperMix was eventually selected due to its high-fidelity Thermococcus polymerase, which has very 
low error rate. The fidelity for sequencing is especially important, as few nucleotides differences in 
sequences may affect the proper allocation of closely related taxa. This master mix has advantage 
of the reaction conditions being pre-optimized. However, the same pre-optimized conditions have 
disadvantage in being relatively rigid for fine tuning the master mix for the reactions that are more 
challenging, such as the minute amount of microbial DNA present in zebrafish oral microbial 
samples. The benefit of high-fidelity outweighed rigidity in the assessment and all the PCR steps 
were performed using this master mix.  
Homebrew sequencing library primers were selected as the initial approach for this project. 
Designing the primers itself provides flexibility in study design and good quality sequencing reads. 
However, the optimization of the PCR conditions proved to be more challenging than was initially 
thought. Problems in PCR might have been associated with length of the primers, which were 
around 80 nucleotides long. In series of PCR reactions, conditions were optimized for concentration 
of reaction components, temperatures for denaturation and annealing steps and experimented 
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with differing lengths of each step. None of the above approaches resulted into PCR protocol, which 
would successfully and consistently multiply sequencing library from the oral and gut samples that 
were mainly used for the pilot study.  
Readily available cultured Mycobacterium marinum DNA was used as a positive control throughout 
the study. Mycobacterium DNA performed well as positive control, it was much more effectively 
amplified in PCR than sample DNA, thus indicating if adjustments to the protocol were bringing 
working protocol closer or not. The first successes of PCR came from protocol where two different 
annealing temperatures were used. The intention was to first use annealing temperature that was 
calculated based on the annealing temperature of the portion of the primers that are 
complementary to the 16S gene and then raise annealing temperature to match whole primer 
sequence.  
Two-step process described above appeared initially promising when tested with M. marinum 
samples. However, test runs with oral and gut microbial samples did not yield consistent results 
with yield and specificity of the reaction. Some samples produced bright bands of the correct length 
once run on 1% agarose gel, but increasing the cycles up to 40, did not result in visible bands in 
others. Also, the protocol in those samples, that show good amplification, were not consistent 
between different runs. One of the factors leading to inconsistent results could be sample DNA 
deterioration. With each DNA extraction sets, multiple PCR runs were performed. Through earliest 
sample extraction sets, DNA was not divided into aliquots, thus those samples went through 
multiple freeze-thawing cycles, which have potentially accelerated the degradation. As two sample 
sets were aliquoted and stored in -80°C with not much better success in amplification efficiency, it 
remains speculation if degradation of template DNA affected the results in PCR runs. It is possible 
to speculate, that if the tested protocols would have worked, there would have been at least some 
visible evidence of the success even in the sample set most exposed to degradative conditions, since 
PCR rounds in the test runs were abundant. 
7.2.1 Exonuclease treatment 
Consistently, in addition to successful PCR amplification, there was leftover primers that were not 
consumed during PCR. As the sequencing efficiency with MiSeq is reliant on the mass of the 
sequencing tags, the primers would have had major undesired impact on the cluster formation. One 
approach for purifying unbound primers from the samples after PCR is treating them with 
exonucleases, which digest the single stranded DNA including 5’-overhangs on double stranded 
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fragments. As this protocol was used in our lab before, it was logical way of treating the amplified 
samples before sequencing. However, the standard protocol had poor efficiency, as it failed to 
remove excess primers. The incubation time was increased to make the reaction perform better. 
Neither gave this method good results. The enzymes used had been proved to work earlier, so this 
has to do with the reaction conditions or the sheer amount of substrate, which was present in 
abundance in these test samples. However, it was concluded that other measures are worth 
exploring for sample purification as continuing with exonuclease would have meant impractically 
lengthy treatment times or some optimization for reaction conditions before the working protocol 
would have been found.  
7.3 Nextera XT Library Preparation Kit 
Due to failures in attempts to utilize PCR for library creation, the enzymatic tagmentation approach 
with Nextera XT Library Preparation Kit was used. This method produced sequencing library that 
was enough to complete this project, while still not being optimal protocol for library creation. 
7.3.1 AMPure XP Beads 
AMPure XP beads are purification method for double stranded DNA, in which DNA is bound to 
metallic beads that can be then separated from other substances, by discarding the supernatant 
once beads are bound to the wall of microcentrifuge tube with help of magnetic stand. With the 
method, there is also possibility to do size selection of the purified DNA fragments by altering the 
beads to DNA ratio. In this project the method was used two times for sample purification. There 
are no data for purity concerning other substances than DNA, but the size selection which was 
sought after, was not as efficient as expected and thus gel extraction was needed to specifically 
select the correct sized library for sequencing. 
7.3.2 Fragment analyser 
The quantitation of the sequencing library is essential for the success of optimal clustering in the 
sequencer flow cell. Since cluster density is dependent on the molarity of library molecules, 
information of sheer w/v concentration is not enough for properly defining final library volume as 
small fragments can overfill the channels and fragments larger than anticipated library would leave 
clustering density lower than optimal. Therefore, libraries must be analysed with methods that can 
measure the exact size distribution in the sample. Fragment analyser was selected for the purpose 
due to its easy availability and for the high-quality data it provides. Also, the fragment analyser can 
run the analysis with low amount of sample, thus preserving valuable sample. In the project 
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fragment analyser was used twice as first round revealed lot of background DNA that had to be 
removed, as AMPure XP beads failed to remove it even when it was performed according to 
protocol. The fragment analysis proved to be powerful method for examining the fragment size, but 
it also has some limitations that prevent its usage in some occasions. If the library contains many 
different sizes of library fragment, it could be difficult to count the amount of library needed for 
sequencing run. In these instances, the library quantification is reasonable to be performed using 
quantitative PCR.  
7.4 Sequencing 
Where creating the sequencing library proved to be difficult, the sequencing itself was successful. 
The cluster density in the flow cell was close to perfect and three fourths of all reads passed the 
quality filtering. The chemistry was nearly six months past the expiry date when used, but it did not 
seem to significantly affect the quality, which proved that good results can also be obtained using 
expired sequencing chemistry.  
7.4.1 Data analysis 
The data analysis was performed using DADA2 R-package (Callahan et al., 2016), which filtered 
irrelevant reads in multiple steps. Quality filtering removed on average 21% and chimera removal 
another 22% of the reads, and in total all the filtering steps reduced the number of reads to just 53% 
of the original reads. Even after filtering there were on average approximately 65000 reads per 
sample. When the sequencing depth was assessed with rarefaction curve, the amount of reads per 
sample was proved to be enough to cover the diversity in each sample. 
7.5 Zebrafish microbiome 
For microbial ecology studies three individuals are undeniably small sample size, yet sufficient for 
providing valuable information in this pilot study where primary objective was to test the 
sequencing protocol. Despite its secondary nature, the sequencing itself revealed some interesting 
features of the zebrafish microbiota. Species diversity appears to be different between the microbial 
environments, gut samples had 288 unique ASVs whereas oral samples had 401. The taxon 
composition was also different, which can be seen in table 5. It is worth noting that this observed 
species diversity may have been distorted by process of creating the library and potential 
contaminants. Multiple rounds of PCR could have introduced mutations by polymerase, despite the 
high-fidelity polymerase used and amplification bias could have distorted the relative abundances. 
Another source of bias and potentially diversity increasing factor could be contaminating microbial 
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DNA from kits and reagents used for library creation. Salter et al. (2014) studied some commonly 
used extraction kits and reagents and found that especially with small amount of starting material 
the proportion of contaminating DNA can even became dominant.  
According to previous microbial ecology studies conducted with zebrafish gut microbiota (Roeselers 
et al., 2011), different zebrafish populations even between laboratory strains and fish recently 
caught from nature seems to share certain core microbiota. Fusobacteria was systematically present 
in all populations, whereas in this study it had only marginal importance covering only 0.1% of the 
reads. Proteobacteria phylum, which forms majority of reads in gut samples in this study and has 
considerable representation in oral samples, was also present with major percentage in Roeselers 
et al. study, where Aeromonas and Pseudomonas were making significant contribution to the 
microbial abundance. In this study Pseudomonas played smaller role. 
The most interesting observation made based on this study was finding significant proportion of 
Firmicutes from both oral and gut environments. Majority of those reads were characterized as 
uncharacterized Peptostreptococcaceae species that is closely related to genus Paraclostridium. 
One previous study has detected the nearly identical ASV of 16S V3-V4 region from faeces of 
endangered Yangtze finless porpoise (Wan et al., 2016). The genus has two known obligate 
anaerobe member species Paraclostridium benzoelyticum extracted from the marine sediment (Sasi 
Jyothsna et al., 2016) and P. bifermentas which was previously classified as Clostridium but was 
proposed by Sasi Jyothsna et al., (2016) to be moved under this new Paraclostridium genus. P. 
bifermentas can potentially have pathogenic properties. The occurrence of P. bifermentas in mice 
gut correlates with the worsening UC symptoms and decreasing microbiome diversity in UC mouse 
model (Kutsuna et al., 2018). The role of this novel Paraclostridium species for zebrafish microbiotas 
would be interesting to assess in upcoming studies along with the Aeromonas species, which was 
present in great numbers in all samples and which made majority of the bacterial abundance in gut. 
Aeromonas species was not characterized down to species level, but BLAST search of some of the 
ASVs found high similarity >99,5% to A. veronii, yet similarity to several other Aeromonas species 
were also over 99%. As the genus has some known pathogens, it might be worth studying further.  
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8 CONCLUSIONS 
This project ended up with successfully sequenced the zebrafish oral and gut microbiota. PCR 
amplified sequencing library protocol and library creation kit with enzymatic sequencing adapter 
tagmentation was tested. PCR based method failed to give consistent results with library creation, 
where library creation kit produced library that was eventually used for sequencing. There were 
some non-optimally functioning steps during the library creation, which led to deviation from the 
kit protocol.  The sequencing revealed higher diversity in oral samples compared to gut samples, 
also the dominant genera were different in both environments. ASVs annotated to Paraclostridium, 
the most common genus of oral microbiome might belong to uncharacterized species, which is not 
present in other studies of zebrafish microbiota.  
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